EHV-1 has dominated online conversation in recent weeks—but not all the information circulating reflects the science. In this episode of Equine Innovators, we step back from the noise to focus on what researchers and clinicians know about how equine herpesvirus infects horses, how it spreads, why latency matters, and what drives the neurologic form of the disease.
Host Stephanie Church, editorial director at The Horse, speaks with Dr. Abby Sage, equine technical services veterinarian for Zoetis and a former state veterinary official, and Dr. Lutz Goehring, professor of equine infectious diseases at the University of Kentucky’s Gluck Equine Research Center. Sage and Goehring explain what testing can—and cannot—tell us during an outbreak, clarify common misconceptions, and outline how vaccination and biosecurity fit into a thoughtful response.
The conversation also looks ahead, exploring emerging diagnostic tools, vaccine research, and unanswered questions about viral reactivation and neurologic risk. Whether you’re a veterinarian or a horse owner navigating heightened concern, this episode offers grounded perspective and practical context.
In this episode, Dr. Lutz Goehring and Dr. Abby Sage discuss:
How EHV-1 spreads and why outbreaks occur regularly, even when they don’t make headlines
What differentiates respiratory infection from equine herpesvirus myeloencephalopathy
How veterinarians interpret PCR testing and where stall-side tools fit
What vaccination can realistically achieve, and what it cannot
Which biosecurity measures matter most at home and on the road
Where current research on EHV-1 is headed next
Tune in to hear how two equine veterinarians break down equine herpesvirus-1 transmission, testing, neurologic disease, and prevention.
Podden och tillhörande omslagsbild på den här sidan tillhör
TheHorse. Innehållet i podden är skapat av TheHorse och inte av,
eller tillsammans med, Poddtoppen.